AstraZeneca strikes $1 billion deal for Pfizer rare-disease gene therapies By: MarketWatch July 28, 2023 at 11:00 AM EDT Stock gains 5% after AstraZeneca's second-quarter results top analyst expectations. Read More >> Related Stocks: AstraZeneca PLC - American Depositary Shares Biogen Idec Pfizer Reata Pharmaceuticals, Inc. - Class A Common Stock
